NYSE · Financial Statements
Eli Lilly and Company (LLY) Financial Statements
$1257.03
NYSE: LLY
Market Cap $1.18T
Overview Financials Dividend
Eli Lilly and Company most recently reported annual revenue of $65.2B, net profit of $20.6B. Revenue grew at an average annual rate of 21.6% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $28.3B $28.5B $34.1B $45.0B $65.2B Operating Profit $7.9B $8.7B $10.8B $17.0B $29.7B Net Profit $5.6B $6.2B $5.2B $10.6B $20.6B EPS $5.85 $6.57 $5.80 $11.71 $22.95 Op Margin 28.0% 30.3% 31.6% 37.8% 45.6%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $48.8B $49.5B $64.0B $78.7B $112.5B Total Liabilities $39.7B $38.7B $53.1B $64.4B $85.9B Cash $3.8B $2.1B $2.8B $3.3B $7.2B Borrowings $16.9B $16.2B $25.2B $33.6B $42.5B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $7.4B $7.6B $4.2B $8.8B $16.8B Investing Cash Flow $-4.8B $-6.7B $-14.5B $-17.7B $-18.8B Financing Cash Flow $-1.5B $-1.8B $-1.1B $-3.0B $-4.9B Net Cash Flow $161.0M $-1.8B $752.0M $450.0M $4.0B Free Cash Flow $5.4B $4.6B $-3.2B $414.0M $9.0B
Valuation & Return Ratios
Metric Value PEG Ratio 0.42 EV / EBITDA 26.80 FCF Yield 1.80% Quick Ratio 1.00 Interest Coverage 40.43 Return 1Y 54.38% Return 3Y 110.94% Return 5Y 420.38%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .